MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2332/allergolint.13-oa-0679

Медицинская библиотека · Allergology international : official journal of the Japanese Society of Allergology · 2014

Rapamycin attenuates pulmonary allergic vasculitis in murine model by reducing TGF-β production in the lung.

Koizumi Rumi, Sasaki Nobuhito, Nakamura Yutaka, Suzuki Naomi, Sawai Takashi, Yamauchi Kohei

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Rapamycin has been reported to inhibit mesenchymal cell proliferation in a murine model of pulmonary fibrosis. In the present study, we examined the effects of rapamycin on vascular remodeling including intraluminal myofibroblast proliferation in a murine model of allergic vasculitis with eosinophil infiltration.

METHODS

C57BL/6 mice were sensitized with ovalbumin (OVA) and alum. The positive controls were exposed to aerosolized OVA daily for 7 days. The other group of mice was administered with rapamycin (1mg/kg) intraperitoneally, in parallel with daily exposure to aerosolized OVA for 7 days. On the 3rd and 7th day, bronchoalveolar lavage (BAL) was performed and the lungs were excised for pathological analysis. Cell differentials were determined and concentrations of IL-4, IL-5, IL-13 and TGF-β in the BAL fluid (BALF) were measured. Semi-quantitative analysis of pathological changes in the pulmonary arteries was evaluated according to the severity of vasculitis.

RESULTS

The number of eosinophils in BALF was reduced significantly in the mice treated with rapamycin compared to the positive control. There was a significant decrease in the TGF-β concentration of the BALF in the rapamycin-treated group compared to that of the positive control. The pathological scores were reduced significantly in the rapamycin-treated group compared to the positive control group. Intraluminal myofibroblasts in pulmonary arteries were reduced dramatically in the rapamycin-treated group compared to the positive control group.

CONCLUSIONS

Rapamycin suppressed pulmonary vascular remodeling in a murine model of allergic vasculitis with eosinophil infiltration through reducing eosinophil infiltration and TGF-β production in the lung and inhibition against biological action of TGF-β.

Для цитирования: Koizumi Rumi, Sasaki Nobuhito, Nakamura Yutaka, Suzuki Naomi, Sawai Takashi, Yamauchi Kohei. Rapamycin attenuates pulmonary allergic vasculitis in murine model by reducing TGF-β production in the lung.. Allergology international : official journal of the Japanese Society of Allergology. 2014. DOI: 10.2332/allergolint.13-oa-0679.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.